Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10648studies shown

Showing 8,641-8,652 of 10,648

Drug study icon

CompletedNCT00177164

Risperdal Consta for Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Bipolarity

Drug study icon

CompletedNCT01411085

Risperidone and Desipramine in Alcohol Use and Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia

Drug study icon

CompletedNCT00176202

Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 10 Years to 20 Years

Countries: United States
Sponsor: University of Illinois at Chicago
Condition: Bipolarity

Drug study icon

CompletedNCT00167154

Risperidone and Suicide prevention in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SuicidalityDrugFrom 19 Years to 60 Years

Countries: United States
Sponsor: University of Alabama at Birmingham
Condition: Depression, Suicidality

Drug study icon

CompletedNCT00215241

Risperidone Augmentation for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Duke University
Condition: PTSD

Drug study icon

CompletedNCT00297739

Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 7 Years to 12 Years

Countries: United States
Sponsor: Armenteros, Jorge L., M.D., P.A.
Condition: ADHD

Drug study icon

CompletedNCT00289861

Risperidone Augmentation in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Schizophrenia

Drug study icon

CompletedNCT00158028

Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai
Condition: Schizophrenia

Drug study icon

CompletedNCT00208182

Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 19 Years to 64 Years

Countries: United States
Sponsor: Creighton University
Condition: PTSD

Drug study icon

CompletedNCT00130923

Risperidone Long-acting Versus Oral Risperidone in people with Schizophrenia and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Addiction

Drug study icon

CompletedNCT00389493

Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: OCD

Drug study icon

CompletedNCT00294255

Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.